pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
74e6e128-165e-4f5c-8f66-29bf59941753
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-13 21:26:20
Income (reported)
Expenses (reported)
$46,000
Expenses method
B
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

Contact
MATTHEW SCHULZE
Phone
+1 202-735-2285
Address
zip:20005, city:WASHINGTON, state:DC, street:1225 NEW YORK AVENUE, NW, #350

Client

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

State
DC
Country
US
Government-entity client
false
Effective date
2007-08-10

Issues lobbied + lobbyists

HCR — Health Issues

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Stark Self-Referral Reform; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments ; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; federal oversight of laboratory tests including laboratory developed testing services; immigration

Lobbyists: MATTHEW SCHULZE

Government entities lobbied: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

MED — Medical/Disease Research/Clinical Labs

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act

Lobbyists: MATTHEW SCHULZE

Government entities lobbied: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

LBR — Labor Issues/Antitrust/Workplace

Physician, clinical laboratory professional, and allied health workforce issues, Federal Funding for Education, Student loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; immigration issues impacting laboratory workforce

Lobbyists: MATTHEW SCHULZE

Government entities lobbied: Bureau of Citizenship & Immigration Services (BCIS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Education, Dept of; Employment & Training Administration; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

MMM — Medicare/Medicaid

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act

Lobbyists: MATTHEW SCHULZE

Government entities lobbied: Bureau of Labor Statistics (BLS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.